Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a new version of the page without changes to study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a technical update to the page version rather than a change to study data or presentation.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, reflecting a minor backend/metadata update to the page.SummaryDifference0.1%

- Check59 days agoChange DetectedIntroduces new help and navigation sections and a recruitment-status note; updates the Intervention/Treatment label and bumps the site revision to v3.6.0, replacing the older 'Intervention / Treatment' label and the v3.5.5 reference.SummaryDifference0.4%

- Check66 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the study record that likely reflects minor maintenance or backend updates.SummaryDifference0.1%

- Check88 days agoChange DetectedFooter shows Revision: v3.5.4, replacing v3.5.3. This indicates a minor version update to the page.SummaryDifference0.1%

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.